Columbia University: Non-alcoholic Fatty Liver Disease trials
The registry lists 12 Non-alcoholic Fatty Liver Disease studies with Columbia University as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 8Phase 2 1Phase 4 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Effect of Insulin Lowering on LipogenesisRecruitingNCT07403604Phase 1
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
- Human Models of Selective Insulin Resistance: Alpelisib, Part IRecruitingNCT06354088Phase 1
- Glycemic Effect of Diazoxide in NAFLDCompletedNCT05729282Phase 1Results posted
- Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)TerminatedNCT02500147Phase 4Results posted
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) StudyCompletedNCT01285362Not applicableResults posted
- Dexamethasone/Pancreatic Clamp P&FWithdrawnNCT06126354Phase 1
- Effect of Alpelisib in Healthy VolunteersCompletedNCT05733455Phase 1
- Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
- Effects of ACC Inhibitor on Lipid and Lipoprotein MetabolismWithdrawnNCT04395950Phase 1
- Curcumin for Pediatric Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04109742Phase 2
- NAFLD in Adolescents and Young Adults With PCOSSuspendedNCT02506946